论文部分内容阅读
[目的]依据广州市越秀区2011~2013年的大肠癌筛查数据,分析大肠癌筛查的经济效益和社会效益,为大肠癌筛查的推广提供理论依据。[方法]测定大肠癌筛查的直接成本、直接效益和间接效益,计算筛查成本效果、净效益和效益成本比。[结果]平均初筛1人的成本为25.17元,复筛1人的成本为290.00元,确定1例高危人群成本为62.94元,确诊1例腺瘤性病变的成本为2313.14元,确定1例大肠癌的平均成本需63380.00元;筛查可获益448.54万元,效益成本比为3.63。[结论 ]大肠癌筛查可降低医疗成本,提高早诊早治率,有一定意义。
[Objective] According to the screening data of colorectal cancer in Yuexiu District of Guangzhou from 2011 to 2013, the economic and social benefits of colorectal cancer screening were analyzed to provide a theoretical basis for the promotion of colorectal cancer screening. [Method] The direct cost, direct benefit and indirect benefit of colorectal cancer screening were determined. The cost effectiveness, net benefit and benefit cost ratio of screening were calculated. [Results] The average cost of screening one person was 25.17 yuan and the cost of one person was 290.00 yuan. The cost of one high risk group was 62.94 yuan, the cost of diagnosing one case of adenomatous disease was 2313.14 yuan, and one case was confirmed The average cost of colorectal cancer need 63380.00 yuan; Screening can benefit 4485400 yuan, the benefit cost ratio is 3.63. [Conclusion] Colorectal cancer screening can reduce the medical cost and improve the early diagnosis and early treatment rate, which is of certain significance.